NCT01380509View on ClinicalTrials.gov

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

October 31, 2002

Conditions
To Determine the Bioequivalence Study Under Fasting
Interventions
DRUG

Metronidazole

Capsules, single-dose, fasting

DRUG

Flagyl

Capsules, single-dose, fasting

Trial Locations (1)

H7V 4B4

Algorithme Pharma, Laval

Sponsors

Collaborators (1)

Algorithme Pharma Inc
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT01380509 - Bioavailability Study of Metronidazole Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter